(A and B) Expression of KLRG1 and fate mapping in effector OT-I cells in
the blood following LM infection.
(C) Frequency of KLRG1+, exKLRG1 and KLRG1−
Reporter− cells among OT-I cells in the blood up to 120
days p.i. with LM.
(D) Percentage (top) and number (bottom) of OT-I cell subsets in the
spleen and LN following LM infection. The numbers indicate fold difference in
cell number between days 10 and 120.
(E) Frequency of KLRG1+, exKLRG1 and KLRG1−
Reporter− cells among OT-I cells in the blood up to 100
days p.i. with VSV.
(F) Percentage of KLRG1+, exKLRG1 and
KLRG1− Reporter− cells among OT-I cells
in the spleen and LN 100 days p.i. with VSV.
Mean ± SEM are shown. Data are pooled from 2–4 independent
experiments with 4–12 (C) or 3–12 mice per time point (D), or are
representative of 2–3 independent experiments with 3–5 mice per
time point (A, E, F). See also Figure S1 and S2.